AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.


01/17/2023 | Presentation of BIOSPAIN 2023
On September 26-28, 2023, BIOSPAIN will take place in Barcelona,... More

11/23/2022 | The value of intangibles: Industrial and intellectual property, a strategic element of the company
Next 23/11/2022 will take place, at the College of Economists of Catalonia,... More


03/09/2023 | 1st Congress of Environmental Health and Medicine
Congress of Environmental Health and Medicine in Barcelona on April 21, 2023.... More

01/17/2023 | 1st Multidisciplinary Meeting to address the problem of diseases of environmental origin
Next 26th and 27th January will take place the first multidisciplinary... More